Dina M Flink1, Jeanelle Sheeder2, Laxmi A Kondapalli3. 1. 1 Department of Obstetrics and Gynecology, University of Colorado School of Medicine , Aurora, Colorado. 2. 2 Division of Family Planning, Department of Obstetrics and Gynecology, University of Colorado School of Medicine , Aurora, Colorado. 3. 3 Colorado Center for Reproductive Medicine , Lone Tree, Colorado.
Abstract
PURPOSE: The Fertility Attitudes and Cancer Treatment Study (FACTS) is a two-phase research initiative aimed to understand factors involved with decision making for future fertility. The FACTS will improve services and utilization of fertility preservation (FP) before cancer treatment. Phase-I examined patient characteristics as associated with FP decision. METHODS: A retrospective cohort study of 108 reproductive-aged (18-45 years) males and females who received a fertility consultation before cancer treatment from January 1, 2012 to April 30, 2014 was conducted. Chi-square, student's t-test, and logistic regression were conducted to examine associations with FP decision. RESULTS: The utilization rate of FP following fertility consultation was 49%. Gender was the most significant factor contributing to FP decision; 74% of those who choose FP were male (odds ratio = 12.5; 95% confidence interval 5.1-31.4). Those who opted for FP were more likely to be Caucasian (p = 0.042), have a solid tumor (p = 0.03), and have a shorter time from diagnosis to fertility consultation (29.5 vs. 58.8 days; p = 0.017). Age, relationship, tumor location, treatment plan, and parity were not significant predictors of FP. CONCLUSIONS: Current perceptions about patient demographics do not predict FP utilization by young adult cancer patients. Providing patients an informed fertility consultation has demonstrated an increase in FP utilization to nearly one-half of patients. Despite gender being a significant factor in choosing FP, the study did not provide reasons as to why. The phase-II study will explore patients' reasons for FP decision in a qualitative design to understand these differences.
PURPOSE: The Fertility Attitudes and Cancer Treatment Study (FACTS) is a two-phase research initiative aimed to understand factors involved with decision making for future fertility. The FACTS will improve services and utilization of fertility preservation (FP) before cancer treatment. Phase-I examined patient characteristics as associated with FP decision. METHODS: A retrospective cohort study of 108 reproductive-aged (18-45 years) males and females who received a fertility consultation before cancer treatment from January 1, 2012 to April 30, 2014 was conducted. Chi-square, student's t-test, and logistic regression were conducted to examine associations with FP decision. RESULTS: The utilization rate of FP following fertility consultation was 49%. Gender was the most significant factor contributing to FP decision; 74% of those who choose FP were male (odds ratio = 12.5; 95% confidence interval 5.1-31.4). Those who opted for FP were more likely to be Caucasian (p = 0.042), have a solid tumor (p = 0.03), and have a shorter time from diagnosis to fertility consultation (29.5 vs. 58.8 days; p = 0.017). Age, relationship, tumor location, treatment plan, and parity were not significant predictors of FP. CONCLUSIONS: Current perceptions about patient demographics do not predict FP utilization by young adult cancerpatients. Providing patients an informed fertility consultation has demonstrated an increase in FP utilization to nearly one-half of patients. Despite gender being a significant factor in choosing FP, the study did not provide reasons as to why. The phase-II study will explore patients' reasons for FP decision in a qualitative design to understand these differences.
Authors: Kunj R Sheth; Vidit Sharma; Brian T Helfand; John Cashy; Kristin Smith; Jason C Hedges; Tobias S Köhler; Teresa K Woodruff; Robert E Brannigan Journal: J Urol Date: 2012-01-20 Impact factor: 7.450
Authors: Rebecca J Lee; Ann Wakefield; Sharon Foy; Sacha J Howell; Andrew M Wardley; Anne C Armstrong Journal: Psychooncology Date: 2010-09-02 Impact factor: 3.894
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Paul B Jacobsen; Caprice Knapp; David L Keefe; Geri E Bell Journal: J Midwifery Womens Health Date: 2010 Mar-Apr Impact factor: 2.388
Authors: Ursula Balthazar; Allison M Deal; Marc A Fritz; Laxmi A Kondapalli; Ja Yeon Kim; Jennifer E Mersereau Journal: Hum Reprod Date: 2012-06-06 Impact factor: 6.918
Authors: James L Klosky; Mary E Randolph; Fariba Navid; Heather L Gamble; Sheri L Spunt; Monika L Metzger; Najat Daw; E Brannon Morris; Melissa M Hudson Journal: Pediatr Hematol Oncol Date: 2009-06 Impact factor: 1.969
Authors: Erin M Mobley; Ginny L Ryan; Amy E Sparks; Varun Monga; William W Terry Journal: J Adolesc Young Adult Oncol Date: 2019-10-25 Impact factor: 2.223